IDSA updates guidance for antimicrobial-resistant gram-negative infections

• by Meg Barbor

• August 21, 2026

Expert panel endorse individualized beta-lactam dosing for acutely ill patients

International guidance supports concentration-guided dosing for selected acutely ill patients, with clinical cure showing the clearest benefit.

• by Doug Brunk

• August 17, 2026

• 7 min

DOOR framework shows similar outcomes in skin infection trials

“Using DOOR can provide clinicians and patients with a better understanding of the benefits and risks of new anti-infectives being studied to treat skin infections.” 

• by Matthew Solan

• August 24, 2026

• 7 min

Diagnostic accuracy of rapid diagnostic tests for vibrio cholerae serogroups O1 and O139: A systematic review and meta-analysis

• by Xitong Yao, Han Wang, Kuo Jiang, Shengyuan Wang, Wenjun Li, Zhun Wang, Yanfei Qi

• July 15, 2026